What Are Wall Street Analysts' Target Price for Becton, Dickinson and Company Stock?

With a market cap of $54.2 billion, Becton, Dickinson and Company (BDX) is a leading medical technology firm headquartered in Franklin Lakes, New Jersey. The company develops, manufactures, and sells a wide range of medical devices, laboratory equipment, and diagnostic products used in healthcare, research, and clinical settings. BD operates through three key segments: BD Medical, BD Life Sciences, and BD Interventional, serving hospitals, laboratories, and pharmaceutical companies worldwide. 

Shares of the medical device titan have underperformed the broader market over the past 52 weeks. BDX stock has decreased 16.9% over this time frame, while the broader S&P 500 Index ($SPX) has gained 14.5%. Moreover, shares of the company have declined 15.3% on a YTD basis, compared to SPX's 16.5% rise.